Zydus’ Desidustat shows efficacy and safety in treating Hypoxia in hospitalized Covid-19 patients in Mexico Novel mechanism of targeting ‘hypoxia’ through HIF-PH inhibitor was studied for the first time in Hospitalised Covid-19 Patients in Mexico Phase (2) b Trial data shows the potential of Desidustat